Therapy Dual-8 Ablation Catheter
Irvine Biomedical,Inc.(Ibi) · Decision date Sep 3, 2026
What did the FDA decide?
The FDA record for P040042/S060 describes a 30-day notice supplement to PMA P040042, submitted by Irvine Biomedical, Inc. (IBI) for the Therapy Dual-8 Ablation Catheter, a percutaneous cardiac ablation catheter for treatment of atrial flutter (product code OAD). The stated purpose is to add an alternate epoxy in the manufacture of the temperature sensor. The record classifies this as a process change involving a manufacturer, sterilizer, packager or supplier, and lists the decision as OK30 dated 2026-09-03.
The identifier establishes that this is a supplement to the original P040042 approval, not a new approval of the whole system. The record states only the intended change: an alternate epoxy for the temperature sensor. It does not specify the epoxy's identity, the sensor design, which manufacturing step changes, or whether prior epoxy use continues. The statement does not show independent evidence of safety or clinical effectiveness, and no new indication or clinical use is recorded.
FDA approval order statement
to add an alternate epoxy in the manufacture of the temperature sensor
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 3, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P040042/S060
- Regulatory pathway
- PMA supplement
- Applicant
- Irvine Biomedical,Inc.(Ibi)
- Product code
- OAD
- Decision code
- OK30
- Decision date
- Sep 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter.
- Applicant
- Irvine Biomedical,Inc.(Ibi)
- Product code
- OAD
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P040042. Subsequent supplements may change the device or its indications.
FDA decision timeline
P040042 · Original PMA
THERAPY DUAL 8 CARDIAC ABLATION SYSTEM,THERAM 8MM THERMISTER ABLATION CATHETER SAFIRE TX ABLATION CATHETER
P040042/S060 received
Application receipt date recorded by FDA.
P040042/S060 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P040042. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P040042
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Irvine Biomedical,Inc.(Ibi) | PMA approval | Nov 18, 2005 | FDA |
Explore the linked device profile
Other records with product code OAD
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biosense Webster, Inc. | PMA supplement | Sep 15, 2026 | FDA | |
THERMOCOOL SMARTTOUCH SF CatheterP030031/S142 | Biosense Webster, Inc. | PMA supplement | Sep 2, 2026 | FDA |
| Biosense Webster, Inc. | PMA approval | Nov 5, 2004 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Irvine Biomedical,Inc.(Ibi)
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 2375 Morse Ave., Irvine, CA, 92614
Sources and methodology
- Original FDA record: P040042/S060
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records